Atlas Trials

An Open, Single Center, Non-randomized, Single Arm Clinical Study of Evaluating the Efficacy of Selinexor in the Maintenance Treatment of PTCL

Clinical trial NCT05822050 · UNKNOWN

Trial details

NCT number
NCT05822050
Sponsor
The First Hospital of Jilin University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
PTCL Patients Who Achieved Complete Response From Frontline Treatment
Start date
2023-06-01
Primary completion
2024-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.